174 related articles for article (PubMed ID: 6120758)
1. New antitumor imidazole derivative, 5-carbamoyl-1H-imidazol-4-yl piperonylate, as an inhibitor of purine synthesis and its activation by adenine phosphoribosyltransferase.
Fukui M; Inaba M; Tsukagoshi S; Sakurai Y
Cancer Res; 1982 Mar; 42(3):1098-102. PubMed ID: 6120758
[TBL] [Abstract][Full Text] [Related]
2. Collateral sensitivity of 6-mercaptopurine-resistant sublines of P388 and L1210 leukemia to the new purine antagonists, 5-carbamoyl-1H-imidazol-4-yl piperonylate and 4-carbamoylimidazolium 5-olate.
Inaba M; Fukui M; Yoshida N; Tsukagoshi S; Sakurai Y
Cancer Res; 1982 Mar; 42(3):1103-6. PubMed ID: 6277474
[TBL] [Abstract][Full Text] [Related]
3. Selective reduction of intracellular guanosine 5'-triphosphate pool by 4-carbamoylimidazolium 5-olate in murine tumor cells.
Fukui M; Inaba M; Tsukagoshi S; Sakurai Y
Cancer Res; 1986 Jan; 46(1):43-6. PubMed ID: 2866032
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of phosphoribosylation of 5-fluorouracil by purines.
Yoshida M; Hoshi A; Kuretani K
Nucleic Acids Symp Ser; 1980; (8):s175-8. PubMed ID: 6789308
[TBL] [Abstract][Full Text] [Related]
5. Lesch-Nyhan syndrome: the synthesis of inosine 5'-phosphate in the hypoxanthine-guanine phosphoribosyltransferase-deficient erythrocyte by alternate biochemical pathways.
Lowy BA; Williams MK
Pediatr Res; 1977 May; 11(5):691-4. PubMed ID: 870876
[TBL] [Abstract][Full Text] [Related]
6. Enzymic capacities of purine de Novo and salvage pathways for nucleotide synthesis in normal and neoplastic tissues.
Natsumeda Y; Prajda N; Donohue JP; Glover JL; Weber G
Cancer Res; 1984 Jun; 44(6):2475-9. PubMed ID: 6327016
[TBL] [Abstract][Full Text] [Related]
7. Mode of action of 2-amino-6-chloro-1-deazapurine.
Bennett LL; Smithers D; Rose LM; Adamson DJ; Brockman RW
Biochem Pharmacol; 1984 Jan; 33(2):261-71. PubMed ID: 6142712
[TBL] [Abstract][Full Text] [Related]
8. A novel mechanism of mycophenolic acid resistance in the protozoan parasite Tritrichomonas foetus.
Hedstrom L; Cheung KS; Wang CC
Biochem Pharmacol; 1990 Jan; 39(1):151-60. PubMed ID: 1967525
[TBL] [Abstract][Full Text] [Related]
9. Altering the purine specificity of hypoxanthine-guanine-xanthine phosphoribosyltransferase from Tritrichomonas foetus by structure-based point mutations in the enzyme protein.
Munagala NR; Wang CC
Biochemistry; 1998 Nov; 37(47):16612-9. PubMed ID: 9843428
[TBL] [Abstract][Full Text] [Related]
10. Adenine phosphoribosyltransferase deficiency in cultured mouse mammary tumor FM3A cells resistant to 4-carbamoylimidazolium 5-olate.
Koyama H; Kodama H
Cancer Res; 1982 Oct; 42(10):4210-4. PubMed ID: 7105014
[TBL] [Abstract][Full Text] [Related]
11. Significance of purine salvage in circumventing the action of antimetabolites in rat hepatoma cells.
Natsumeda Y; Ikegami T; Olah E; Weber G
Cancer Res; 1989 Jan; 49(1):88-92. PubMed ID: 2461800
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of inhibition of phosphoribosylation of 5-fluorouracil by purines.
Yoshida M; Hoshi A
Biochem Pharmacol; 1984 Sep; 33(18):2863-7. PubMed ID: 6206872
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor-dependent metabolism of hypoxanthine via the salvage pathway for purine synthesis in porcine aortic endothelial cells.
Hirai S; Hayashi Y; Koizumi T; Nakanishi N; Fukui T; Ichikawa A
Biochem Pharmacol; 1993 Apr; 45(8):1695-701. PubMed ID: 7683470
[TBL] [Abstract][Full Text] [Related]
14. Purine salvage in Schistosoma mansoni schistosomules.
Dovey HF; McKerrow JH; Wang CC
Mol Biochem Parasitol; 1984 Apr; 11():157-67. PubMed ID: 6431283
[TBL] [Abstract][Full Text] [Related]
15. Effects of 2-amino-1,3,4-thiadiazole on ribonucleotide pools of leukemia L1210 cells.
Nelson JA; Rose LM; Bennett LL
Cancer Res; 1976 Apr; 36(4):1375-8. PubMed ID: 130972
[TBL] [Abstract][Full Text] [Related]
16. De novo synthesis of purine nucleotides in human peripheral blood leukocytes. Excessive activity of the pathway in hypoxanthine-guanine phosphoribosyltransferase deficiency.
Brosh S; Boer P; Kupfer B; de Vries A; Sperling O
J Clin Invest; 1976 Aug; 58(2):289-97. PubMed ID: 956368
[TBL] [Abstract][Full Text] [Related]
17. Purine metabolic cycle in normal and leukemic leukocytes.
Dietz AA; Czebotar V
Cancer Res; 1977 Feb; 37(2):419-26. PubMed ID: 188545
[TBL] [Abstract][Full Text] [Related]
18. Purine metabolism in myeloid precursor cells during maturation. Studies with the HL-60 cell line.
Lucas DL; Webster HK; Wright DG
J Clin Invest; 1983 Dec; 72(6):1889-900. PubMed ID: 6139386
[TBL] [Abstract][Full Text] [Related]
19. Increased sensitivity to oxanosine, a novel nucleoside antibiotic, of rat kidney cells upon expression of the integrated viral src gene.
Uehara Y; Hasegawa M; Hori M; Umezawa H
Cancer Res; 1985 Nov; 45(11 Pt 1):5230-4. PubMed ID: 2413989
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of two enzymes in de novo purine nucleotide synthesis by triciribine phosphate (TCN-P).
Moore EC; Hurlbert RB; Boss GR; Massia SP
Biochem Pharmacol; 1989 Nov; 38(22):4045-51. PubMed ID: 2480792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
